Physician profile
Aaron Friedman
NPI 1194751925
$11,273.79
in general payments reported to CMS, 2019-2025
22 companies · $59.39 in 2025
The $59.39 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $7,254 · 2021: $2,486 · 2022: $800 · 2023: $205 · 2024: $75.43 · 2025: $59.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $8,652.92 | 2020-2021 | |
| Abbvie INC. | $675.62 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $505.90 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $268.95 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $253.89 | 2022 | |
| Amgen INC. | $168.25 | 2019-2022 | |
| Medtronic USA, INC. | $124.89 | 2019 | |
| Pfizer INC. | $104.07 | 2023 | |
| Jazz Pharmaceuticals INC. | $70.00 | 2019-2020 | |
| Ucb, INC. | $60.25 | 2024-2025 | Briviact |
| Upsher-Smith Laboratories LLC | $54.94 | 2020-2022 | |
| Grt US Holding, INC. | $51.13 | 2022 | |
| Lundbeck LLC | $44.50 | 2020-2023 | Vyepti |
| Lilly USA, LLC | $42.12 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $41.99 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $36.98 | 2019 | |
| Neurelis, INC. | $27.86 | 2025 | Valtoco |
| Abbott Laboratories | $22.93 | 2021 | |
| Boston Scientific Corporation | $20.53 | 2023 | |
| Zyla Life Sciences, INC. | $15.76 | 2019 | |
| Acacia Pharma INC | $15.57 | 2021 | |
| Daiichi Sankyo INC. | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.